Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Carfilzomib combinations in ENDEAVOR and FORTE

Prof Katja Weisel - University of Tübingen, Tübingen, Germany
Carfilzomib combinations in ENDEAVOR and FORTE ( Prof Katja Weisel - University of Tübingen, Tübingen, Germany )
23 Jun 2017

Deep molecular response to gilteritinib in CHRYSALIS trial

Dr Jessica Altman - Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA
Deep molecular response to gilteritinib in CHRYSALIS trial ( Dr Jessica Altman - Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA )
23 Jun 2017

Dual JAK/SYK inhibition in refractory NHL with cerdulatinib

Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017

Diverse T lymphocyte population fights leukaemia more effectively

Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany
Diverse T lymphocyte population fights leukaemia more effectively ( Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany )
23 Jun 2017

Delayed exposure to common infections causes acute childhood leukaemia

Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical Immunology, Düsseldorf, Germany
Delayed exposure to common infections causes acute childhood leukaemia ( Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical Immunology, Düsseldorf, Germany )
23 Jun 2017

Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL

Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017

European guidelines for breast cancer treatment

Dr Ciarán Nicholl - Research Centre Ispra, European Commission, Belgium
European guidelines for breast cancer treatment ( Dr Ciarán Nicholl - Research Centre Ispra, European Commission, Belgium )
19 Jun 2017

The European Alliance for Personalised Medicine

Denis Horgan - European Alliance for Personalised Medicine, Belgium
The European Alliance for Personalised Medicine ( Denis Horgan - European Alliance for Personalised Medicine, Belgium )
19 Jun 2017

EUPATI and patient involvement

Paola Kruger - Patient Expert, EUPATI Fellow
EUPATI and patient involvement ( Paola Kruger - Patient Expert, EUPATI Fellow )
19 Jun 2017

ESMO ranking of the clinical benefits of new drugs

Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy
ESMO ranking of the clinical benefits of new drugs ( Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy )
19 Jun 2017

Cancer and the workplace

Prof Diana Kloss - Manchester University, Manchester, UK
Cancer and the workplace ( Prof Diana Kloss - Manchester University, Manchester, UK )
19 Jun 2017

The recent past and near future of drug approvals in Europe

Prof Filippo de Braud - Istituto Nazionale dei Tumori, Milan, Italy
The recent past and near future of drug approvals in Europe ( Prof Filippo de Braud - Istituto Nazionale dei Tumori, Milan, Italy )
19 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation